North America EEG Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product; Application; Device Type; End User

32-channel EEG Segment has the Largest Share of Product in the North America EEG Devices Market during 2021-2028

According to a new market research study on “North America EEG Devices Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Product, Application, Device Type, and End-user” is expected to reach US$ 733.5 million by 2028 from US$ 436.1 million in 2021. The market is estimated to grow at a CAGR of 7.7% from 2021 to 2028. The report provides trends prevailing in the North America EEG devices market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the growing incidences of neurovascular disorders and significantly rising elderly population are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the high cost of EEG devices.

Due to coronavirus spreading, many cities are shutting down, causing treatments and doctors/surgeons appointment cancellations. The patients suffering from critical surgeries such as spinal surgery, neurosurgery, and ENT surgery need physical awareness and need to implement procedures in the clinics. The procedure includes Intraoperative Neuromonitoring by systems, services, and accessories. Moreover, companies are also focused on manufacturing COVID diagnostics and related products. For instance, in June 2020, Ceribell Inc. a Mountain View, Calif.-based startup, deployed its cloud-linked, portable electroencephalogram (EEG) device to enable EEG assessments in minutes in emergency rooms and intensive care units. The Rapid Response EEG system is used in the Montefiore Health System in New York and at Northwell Health’s North Shore University Hospital, providers at the epicenter of the US COVID-19 crisis. Also, in April 2020, Fresenius Medical Care entered multiple partnerships with other dialysis providers to combat the COVID19 pandemic in the US. In North America, Fresenius Medical Care has collaborated with DaVita Inc. and other dialysis service providers to respond to COVID-19. This partnership is aimed to provide and support the broader kidney care community in the US by offering isolation capacity for dialysis patients infected by COVID-19. Therefore, COVID-19 had a negative impact on the EEG devices market.

The market for EEG devices market is segmented into product, application, device type, and End-user. Based on product, the EEG devices market is segmented into 32-channel EEG, 25-channel EEG, 40-channel EEG, Multi-channel EEG, 21-channel EEG, and 8-channel EEG. In 2021, the 32-channel EEG segment is estimated to account for the largest market share in the EEG devices market. Technological development in 32-channel EEG products and its high acceptance by healthcare professionals are the major factors driving the growth of the segment. Owing to factors such as increasing usage in the 32-channel EEG segment is anticipated to grow in the future. However, the multi-channel EEG systems are projected to grow at the highest CAGR over the forecast period, owing to its various applications in recording electrical activities in the brain to detect strokes, neurological disorders, and other brain disorders.

Koninklijke Philips N.V. Bitbrain Technologies, Brain Products GmbH, g.tec medical engineering GmbH Austria, Cognionics, Inc. Wearable Sensing, Neuroelectrics, ANT Neuro, Mitsar Co. LTD. NeuroSky, BioSemi, EMOTIV, InteraXon Inc, and Advanced Brain Monitoring are among the leading companies in the North America EEG devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in March 2020, the company introduced a brand new 14-channel mobile brainwear EPOC X on its 10th Anniversary. The product launch has further enabled neuroscience research in different contexts with an updated sustainable design.

The market for EEG devices market is segmented into product, application, device type, and End-user. Based on product, the EEG devices market is segmented into 32-channel EEG, 25-channel EEG, 40-channel EEG, Multi-channel EEG, 21-channel EEG, and 8-channel EEG. Based on application, the EEG devices market is segmented into sleep disorders, neuroscience, head trauma, brain tumours, and others. Based on device type, the EEG devices market is segmented into standalone devices, and portable devices. Based on End-user, the EEG devices market is segmented into hospitals & clinics, diagnostic centres, academic & research institutes, and research centres. Geographically, the EEG devices market is segmented into North America (US, Canada, Mexico)

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America EEG devices market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the North America EEG devices market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the EEG devices market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution